{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "a-third-party", "type": "clause", "offset": [6, 19]}, {"key": "production-process", "type": "definition", "offset": [78, 96]}], "size": 28, "snippet": "means a Third Party with which COMPANY collaborates on the development of the production process and/or commercialization of a Product or to which COMPANY has granted a license for the development of the production process and/or commercialization of a Product.", "samples": [{"hash": "6at63yGCccj", "uri": "/contracts/6at63yGCccj#collaboration-partner", "label": "Commercial License Agreement (GTX Inc /De/)", "score": 30.2648868561, "published": true}, {"hash": "lgjpmrG8DtB", "uri": "/contracts/lgjpmrG8DtB#collaboration-partner", "label": "Commercial License Agreement (Coherus BioSciences, Inc.)", "score": 25.7310066223, "published": true}, {"hash": "cGuwtM4t7Jh", "uri": "/contracts/cGuwtM4t7Jh#collaboration-partner", "label": "Commercial License Agreement (Coherus BioSciences, Inc.)", "score": 25.7310066223, "published": true}], "hash": "389700647b2497c8c75d4c60e1f7de78", "id": 1}, {"snippet_links": [{"key": "any-person", "type": "clause", "offset": [6, 16]}, {"key": "license-to-develop", "type": "clause", "offset": [58, 76]}, {"key": "of-the-company", "type": "clause", "offset": [117, 131]}], "size": 23, "snippet": "means any Person that co-develops or co-markets (or has a license to develop, market or sell) any product or service of the Company.", "samples": [{"hash": "6FYyQhxmSHI", "uri": "/contracts/6FYyQhxmSHI#collaboration-partner", "label": "Stock Exchange Agreement (Invitae Corp)", "score": 28.4469547272, "published": true}, {"hash": "bZol60DMNng", "uri": "/contracts/bZol60DMNng#collaboration-partner", "label": "Stock Purchase Agreement (Invitae Corp)", "score": 27.0143737793, "published": true}, {"hash": "fvycFFI5p5s", "uri": "https://d18rn0p25nwr6d.cloudfront.net/CIK-0001501134/92e9330c-7741-46e0-824c-44f027f54044.pdf", "label": "d18rn0p25nwr6d.cloudfront.net", "score": 11.0643396378, "published": false}], "hash": "bae4b7c8a06b4b4bba8aafc9965360c8", "id": 2}, {"snippet_links": [{"key": "defined-in-section", "type": "clause", "offset": [3, 21]}, {"key": "the-agreement", "type": "clause", "offset": [33, 46]}], "size": 16, "snippet": "is defined in Section 3.13(b) of the Agreement.", "samples": [{"hash": "fuAdR054RUw", "uri": "/contracts/fuAdR054RUw#collaboration-partner", "label": "Merger Agreement (CymaBay Therapeutics, Inc.)", "score": 35.1136207581, "published": true}, {"hash": "cN3DSGgNmHQ", "uri": "/contracts/cN3DSGgNmHQ#collaboration-partner", "label": "Merger Agreement (Gilead Sciences Inc)", "score": 31.7022590637, "published": true}, {"hash": "5CqT2Kmo2d3", "uri": "/contracts/5CqT2Kmo2d3#collaboration-partner", "label": "Merger Agreement (Immunomedics Inc)", "score": 31.7022590637, "published": true}], "hash": "9eed1b8376ea238ba57feba3388ac65a", "id": 3}, {"snippet_links": [{"key": "the-recipient", "type": "clause", "offset": [18, 31]}, {"key": "small-and-medium", "type": "clause", "offset": [57, 73]}, {"key": "research-institute", "type": "definition", "offset": [120, 138]}, {"key": "secondary-institution", "type": "definition", "offset": [182, 203]}, {"key": "in-canada", "type": "definition", "offset": [204, 213]}, {"key": "the-collaboration", "type": "clause", "offset": [238, 255]}], "size": 10, "snippet": "means, other than the Recipient and sub-contractors, any small and medium-sized Canadian based enterprise, any Canadian research institute, any licensed or accredited academic, post-secondary institution in Canada that is/are involved in the Collaboration.", "samples": [{"hash": "38i6mpO8lnl", "uri": "/contracts/38i6mpO8lnl#collaboration-partner", "label": "Sif Agreement (Xanadu Quantum Technologies Inc.)", "score": 37.1451072693, "published": true}, {"hash": "eJVnbu5iyBw", "uri": "/contracts/eJVnbu5iyBw#collaboration-partner", "label": "Sif Agreement (Xanadu Quantum Technologies Inc.)", "score": 37.0739212036, "published": true}, {"hash": "ja3QSPh0tsJ", "uri": "/contracts/ja3QSPh0tsJ#collaboration-partner", "label": "Strategic Innovation Fund Agreement (Edesa Biotech, Inc.)", "score": 34.9520874023, "published": true}], "hash": "9671db9f08bd5be4760561e8de3725a3", "id": 4}, {"snippet_links": [{"key": "and-company", "type": "clause", "offset": [16, 27]}, {"key": "entered-into", "type": "clause", "offset": [50, 62]}, {"key": "collaboration-arrangement", "type": "definition", "offset": [65, 90]}], "size": 6, "snippet": "means \u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 and Company, with whom AMYLIN has entered into a collaboration arrangement regarding Product.", "samples": [{"hash": "inVNn1SCNIE", "uri": "/contracts/inVNn1SCNIE#collaboration-partner", "label": "Commercial Supply Agreement (Amylin Pharmaceuticals Inc)", "score": 21.0, "published": true}, {"hash": "gjoJ9nJtK9j", "uri": "/contracts/gjoJ9nJtK9j#collaboration-partner", "label": "Commercial Supply Agreement (Amylin Pharmaceuticals Inc)", "score": 21.0, "published": true}, {"hash": "2RQKWzagqxT", "uri": "/contracts/2RQKWzagqxT#collaboration-partner", "label": "Manufacturing Agreement (Amylin Pharmaceuticals Inc)", "score": 21.0, "published": true}], "hash": "8ae864bd2d51714a4b9c78e54fa4e736", "id": 5}, {"snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "licensed-product", "type": "clause", "offset": [31, 47]}, {"key": "a-third-party", "type": "clause", "offset": [49, 62]}, {"key": "license-to-use", "type": "clause", "offset": [96, 110]}, {"key": "offer-for-sale", "type": "definition", "offset": [118, 132]}, {"key": "right-to-make", "type": "clause", "offset": [211, 224]}], "size": 5, "snippet": "means, with respect to a given Licensed Product, a Third Party to which Genentech has granted a license to use, sell, offer for sale and/or import such Licensed Product, whether or not such license includes the right to make such Licensed Product.", "samples": [{"hash": "8Rg5qHrN4yB", "uri": "/contracts/8Rg5qHrN4yB#collaboration-partner", "label": "Research and License Agreement (Sangamo Biosciences Inc)", "score": 21.0, "published": true}, {"hash": "67ysnu7dg4X", "uri": "/contracts/67ysnu7dg4X#collaboration-partner", "label": "Research and Development (Sangamo Biosciences Inc)", "score": 21.0, "published": true}, {"hash": "attkhVcBxKV", "uri": "https://investor.sangamo.com/static-files/60367e14-4ab7-4cb3-8255-aa522f5dc4bb", "label": "investor.sangamo.com", "score": 9.965092659, "published": false}], "hash": "9757cd7ca86c4bb3a4aeeb73fca11e94", "id": 6}, {"snippet_links": [{"key": "third-party", "type": "definition", "offset": [10, 21]}, {"key": "license-to-manufacture", "type": "clause", "offset": [77, 99]}, {"key": "company-product", "type": "clause", "offset": [130, 145]}], "size": 4, "snippet": "means any third party that manufactures, co-develops or co-markets (or has a license to manufacture, develop, market or sell) any Company Product.", "samples": [{"hash": "7P2hvS3blo2", "uri": "/contracts/7P2hvS3blo2#collaboration-partner", "label": "Agreement and Plan of Merger (Poseida Therapeutics, Inc.)", "score": 35.9021224976, "published": true}, {"hash": "chLv3oLW9it", "uri": "/contracts/chLv3oLW9it#collaboration-partner", "label": "Merger Agreement (Luminex Corp)", "score": 32.2772064209, "published": true}, {"hash": "h6xl14peF8u", "uri": "/contracts/h6xl14peF8u#collaboration-partner", "label": "Merger Agreement (GenMark Diagnostics, Inc.)", "score": 32.2005462646, "published": true}], "hash": "79f1bf69d7d91f4a3bde0050a3ebb93c", "id": 7}, {"snippet_links": [{"key": "entered-into", "type": "clause", "offset": [56, 68]}, {"key": "contractual-relationship", "type": "definition", "offset": [71, 95]}, {"key": "in-the-performance", "type": "clause", "offset": [112, 130]}, {"key": "commercial-activities", "type": "definition", "offset": [167, 188]}, {"key": "in-no-event", "type": "clause", "offset": [205, 216]}, {"key": "the-partnership", "type": "clause", "offset": [246, 261]}, {"key": "competing-contract-manufacturer", "type": "definition", "offset": [267, 298]}, {"key": "for-the-purposes-of-this-agreement", "type": "clause", "offset": [339, 373]}, {"key": "licensed-intellectual-property", "type": "definition", "offset": [440, 470]}], "size": 3, "snippet": "means a Sublicensee with whom TDTx or its Affiliate has entered into a contractual relationship, to collaborate in the performance of any research, development and/or commercial activities, such as [***]. In no event may any entity whose role in the partnership is a Competing Contract Manufacturer be deemed to be a Collaboration Partner for the purposes of this Agreement nor shall any entity which merely receives a sublicense under the Licensed Intellectual Property without such contractual relationship having any of the elements of a collaboration as described in this paragraph.", "samples": [{"hash": "hWVAGZVVnqr", "uri": "/contracts/hWVAGZVVnqr#collaboration-partner", "label": "Exclusive License Agreement (Affinia Therapeutics Inc.)", "score": 33.0082130432, "published": true}, {"hash": "1CzYHXEctyp", "uri": "/contracts/1CzYHXEctyp#collaboration-partner", "label": "Exclusive License Agreement (Affinia Therapeutics Inc.)", "score": 32.8959617615, "published": true}, {"hash": "c0ijuW42qQj", "uri": "https://www.sendd.com/~sendd1/2021/1123/161131/205859A.pdf", "label": "Exclusive License Agreement", "score": 14.9466123581, "published": false}], "hash": "e38ee147992771217cc68c906eba62b2", "id": 8}, {"snippet_links": [{"key": "any-person", "type": "clause", "offset": [6, 16]}, {"key": "license-to-develop", "type": "clause", "offset": [58, 76]}, {"key": "service-of", "type": "clause", "offset": [121, 131]}], "size": 3, "snippet": "means any Person that co-develops or co-markets (or has a license to develop, market or sell) any product, technology or service of CombiMatrix or any CombiMatrix Subsidiary.", "samples": [{"hash": "jfj8NqJpx3h", "uri": "/contracts/jfj8NqJpx3h#collaboration-partner", "label": "Merger Agreement (Invitae Corp)", "score": 28.5811080933, "published": true}, {"hash": "iqJ3eJ7ic2t", "uri": "/contracts/iqJ3eJ7ic2t#collaboration-partner", "label": "Merger Agreement (CombiMatrix Corp)", "score": 28.578371048, "published": true}, {"hash": "1MLSb68oNkr", "uri": "https://d18rn0p25nwr6d.cloudfront.net/CIK-0001501134/0e4887a5-b572-409f-96bf-e4bbb75defab.pdf", "label": "d18rn0p25nwr6d.cloudfront.net", "score": 11.0396986008, "published": false}], "hash": "f1f02181ce453e822965ff94ae46a63b", "id": 9}, {"snippet_links": [{"key": "third-party", "type": "definition", "offset": [10, 21]}, {"key": "the-research", "type": "clause", "offset": [34, 46]}, {"key": "with-respect-to", "type": "clause", "offset": [97, 112]}, {"key": "for-clarity", "type": "clause", "offset": [133, 144]}, {"key": "inbound-license", "type": "definition", "offset": [212, 227]}, {"key": "outbound-license", "type": "clause", "offset": [231, 247]}], "size": 3, "snippet": "means any Third Party involved in the Research, Development, Manufacturing, or Commercialization with respect to any Program (which, for clarity, does not include Purchaser but does include any Third Party to an Inbound License or Outbound License).", "samples": [{"hash": "jv2ozS0945v", "uri": "/contracts/jv2ozS0945v#collaboration-partner", "label": "Asset Purchase Agreement (HOOKIPA Pharma Inc.)", "score": 36.3867225647, "published": true}, {"hash": "7uEFbg5QsWl", "uri": "https://ir.hookipapharma.com/static-files/900097a5-2530-4575-b0e1-9ca93eccb2a9", "label": "ir.hookipapharma.com", "score": 20.3651313782, "published": false}, {"hash": "1Y6iY1IrucV", "uri": "https://ir.hookipapharma.com/static-files/27d84fad-5233-471f-b0e3-fe001f617149", "label": "ir.hookipapharma.com", "score": 20.3651313782, "published": false}], "hash": "2978132e8b2d8899352f46148dffcb6d", "id": 10}], "next_curs": "CmISXGoVc35sYXdpbnNpZGVyY29udHJhY3Rzcj4LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIeY29sbGFib3JhdGlvbi1wYXJ0bmVyIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"title": "Collaboration Partner", "size": 155, "snippet": "means a Third Party with which COMPANY collaborates on the development of the production process and/or commercialization of a Product or to which COMPANY has granted a license for the development of the production process and/or commercialization of a Product.", "id": "collaboration-partner", "examples": ["There are no civil or criminal proceedings pending and served against the Company or, to the Company\u2019s knowledge, the <strong>Collaboration Partners</strong> or, to the Company\u2019s knowledge, any Company or <strong>Collaboration Partner</strong> employee, which involve a matter within or related to the FDA\u2019s jurisdiction and related to the Company or the Company\u2019s Products.", "No Company Product manufactured by the Company is under consideration by the Company for recall, withdrawal, suspension, seizure or discontinuance, or, since the Applicable Date, has been subject to a recall, product advisory notice, withdraw, suspension, seizure or discontinuance (other than for commercial or other business reasons) by the Company or a <strong>Collaboration Partner</strong> (whether voluntarily or otherwise)."], "related": [["alliance-partner", "Alliance Partner", "Alliance Partner"], ["collaboration", "Collaboration", "Collaboration"], ["co-licensed-partner", "Co-licensed partner", "Co-licensed partner"], ["collaboration-compound", "Collaboration Compound", "Collaboration Compound"], ["collaboration-target", "Collaboration Target", "Collaboration Target"]], "related_snippets": [], "updated": "2026-03-27T05:59:04+00:00"}, "json": true, "cursor": ""}}